|11-12-2018 06:58 AM CET - Health & Medicine||
HIV Diagnosis Market Report Provides a Comprehensive Analysis of Current and Future Market Trends, and Emerging Revenues with Key Company Siemens AG, Roche, Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton,
Press release from: P&S Intelligence
The HIV diagnosis market is expected to grow at a CAGR of 8.3% between 2017-2023. The market is likely to grow significantly during the forecast period, due to rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits. In addition, rising healthcare expenditure on HIV and related activities further contributes to the growth of the overall market.
Access Detailed Report Summary at: www.psmarketresearch.com/market-analysis/hiv-diagnosis-ma...
As per the findings of the research, based on products, consumables segment is the largest product category in the HIV diagnosis market. Antibody test has been the largely performed test of the HIV diagnosis market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.
Download Report Sample at: www.psmarketresearch.com/market-analysis/hiv-diagnosis-ma...
market for HIV diagnosis, with the U.S. being the largest contributor to the regional market. Increasing prevalence of HIV/AIDS and advantageous features of point of care instruments and kits have been driving the growth of the North American market. In Europe, the U.K. has been the largest contributor to the market for HIV diagnosis, followed by Germany and France. The HIV diagnosis market is expected to witness the fastest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of HIV, rising healthcare expenditure and increasing frequency of blood transfusions.
Make Enquiry Before Buying the Report: www.psmarketresearch.com/send-enquiry?enquiry-url=hiv-dia...
Considering the increasing incidence of HIV, the UNAIDS estimated that approximately $26.2 billion will be required to respond to the epidemic of HIV infection expected in 2020 and around $23.9 billion will be required for the same, in 2030. The variation in healthcare spending across regions is thought to be related to the relative burden of the disease in that region, which in case of Sub-Saharan Africa is significantly high. The overall healthcare spending on HIV and related activities has increased over the years, which in turn is expected to drive the growth of the HIV diagnosis market.
Some of the key players in the HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.
GLOBAL HIV DIAGNOSIS MARKET SEGMENTATION
o Assays, Kits & Reagents
• Software and Services
By Type of Test
• Antibody Test
o HIV-1 Screening Test
Home Access Dried Blood Spot
o HIV-1 Antibody Confirmatory Test
Indirect Immune Fluorescent Antibody Assays (IFA)
Line Immunoassays (LIA)
Radio-Immunoprecipitation Assays (RIPA)
o HIV-2 & Group O Test
• Viral Load
• Early Infant Diagnosis
• Viral Identification
By End User
• Diagnostic Laboratories
• Research Institutes
• North America
o The U.S.
o The U.K.
o Rest of Europe
o Rest of Asia-Pacific
• Latin America
o Rest of Latin America
• Middle East and Africa
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
News-ID: 1360295 • Views: 116More releases